Moreover, a transgenic mouse model with STAT5BN642H, under the hematopoietic vav-promoter, developed an aggressive CD8+ T-cell leukemia with organ infiltrations by CD8+, CD4+, and γδ T-cells [64,65]. This evidence concerns the gene CD8A and T-cell leukemia.